Treatment of Takayasu's Arteritis with Tumor Necrosis Factor Antagonists

Giovanni Filocamo, Antonella Buoncompagni, Stefania Viola, Anna Loy, Clara Malattia, Angelo Ravelli, Alberto Martini

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Four children with Takayasu's arteritis were treated with tumor necrosis factor antagonists because of disease relapse during conventional therapy or as a first-line agent. Two patients went into remission; in the other 2, the response was partial. Anti-tumor necrosis factor agents can have a role in the treatment of Takayasu's arteritis; further controlled studies are required.

Original languageEnglish
Pages (from-to)432-434
Number of pages3
JournalJournal of Pediatrics
Volume153
Issue number3
DOIs
Publication statusPublished - Sep 2008

Fingerprint

Takayasu Arteritis
Tumor Necrosis Factor-alpha
Recurrence
Therapeutics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Treatment of Takayasu's Arteritis with Tumor Necrosis Factor Antagonists. / Filocamo, Giovanni; Buoncompagni, Antonella; Viola, Stefania; Loy, Anna; Malattia, Clara; Ravelli, Angelo; Martini, Alberto.

In: Journal of Pediatrics, Vol. 153, No. 3, 09.2008, p. 432-434.

Research output: Contribution to journalArticle

Filocamo, Giovanni ; Buoncompagni, Antonella ; Viola, Stefania ; Loy, Anna ; Malattia, Clara ; Ravelli, Angelo ; Martini, Alberto. / Treatment of Takayasu's Arteritis with Tumor Necrosis Factor Antagonists. In: Journal of Pediatrics. 2008 ; Vol. 153, No. 3. pp. 432-434.
@article{dba127afd738465d8bab24882ad0c543,
title = "Treatment of Takayasu's Arteritis with Tumor Necrosis Factor Antagonists",
abstract = "Four children with Takayasu's arteritis were treated with tumor necrosis factor antagonists because of disease relapse during conventional therapy or as a first-line agent. Two patients went into remission; in the other 2, the response was partial. Anti-tumor necrosis factor agents can have a role in the treatment of Takayasu's arteritis; further controlled studies are required.",
author = "Giovanni Filocamo and Antonella Buoncompagni and Stefania Viola and Anna Loy and Clara Malattia and Angelo Ravelli and Alberto Martini",
year = "2008",
month = "9",
doi = "10.1016/j.jpeds.2008.04.049",
language = "English",
volume = "153",
pages = "432--434",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Treatment of Takayasu's Arteritis with Tumor Necrosis Factor Antagonists

AU - Filocamo, Giovanni

AU - Buoncompagni, Antonella

AU - Viola, Stefania

AU - Loy, Anna

AU - Malattia, Clara

AU - Ravelli, Angelo

AU - Martini, Alberto

PY - 2008/9

Y1 - 2008/9

N2 - Four children with Takayasu's arteritis were treated with tumor necrosis factor antagonists because of disease relapse during conventional therapy or as a first-line agent. Two patients went into remission; in the other 2, the response was partial. Anti-tumor necrosis factor agents can have a role in the treatment of Takayasu's arteritis; further controlled studies are required.

AB - Four children with Takayasu's arteritis were treated with tumor necrosis factor antagonists because of disease relapse during conventional therapy or as a first-line agent. Two patients went into remission; in the other 2, the response was partial. Anti-tumor necrosis factor agents can have a role in the treatment of Takayasu's arteritis; further controlled studies are required.

UR - http://www.scopus.com/inward/record.url?scp=49349109030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49349109030&partnerID=8YFLogxK

U2 - 10.1016/j.jpeds.2008.04.049

DO - 10.1016/j.jpeds.2008.04.049

M3 - Article

C2 - 18718263

AN - SCOPUS:49349109030

VL - 153

SP - 432

EP - 434

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 3

ER -